MedPath

hematopoietic stem cell data for autologous hematopoietic stem cell mobilizatio

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0009037
Lead Sponsor
lsan Univeristy Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

? Patients who voluntarily signed the consent form for participation in this clinical trial
? Patients with Lymphoma who used Neurapec (pegteograstim) during previous chemotherapy
? Patients with multiple myeloma who have never used Neurapec (pegteograstim) during previous chemotherapy
? patients with hematologic malignancy undergoing autologous hematopoietic stem cell mobilization as subjects for autologous hematopoietic stem cell transplantation

Exclusion Criteria

? Subjects who do not agree with the prospective observational study
? Patients who have previously used pegylated GCSF other than Neurapec

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CD34+ cell counts, Hematopoietic progenitor cell , CPD item, ImmNeIndex
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath